Quantcast
12 Ways To Reduce Your Cancer Risk - Latest European

12 Ways To Reduce Your Cancer Risk - Latest European Research Embodied In New 12 Point Code

Eric Hopton for redOrbit.com - Your Universe Online The latest European Code Against Cancer (ECAC), listing 12 ways to boost healthier lifestyles and reduce cancer risk, was launched Tuesday at a Virtual Press Conference in Lyon and Luxembourg....

Latest carcinogenesis Stories

2014-10-22 12:29:29

Company Expands IP Portfolio Covering Test Methods to Identify Chromosomal Abnormalities including 3q (TERC) and 5p (TERT) in Cervical Cells GAITHERSBURG, Md., Oct. 22, 2014 /PRNewswire/ -- NeoDiagnostix announced today that the United States Patent and Trademark Office has granted two new patents owned by the company (US Patent No. 8,748,099 and 8,852,865) covering the detection of chromosomal abnormalities in cervical samples. The recently issued patents cover methods for...

2014-09-29 08:32:13

SYDNEY, Sept. 29, 2014 /PRNewswire/ -- Novogen Ltd. (ASX: NRT, NASDAQ: NVGN) CEO & Chairman, Dr Graham Kelly, conducted an interview with ABC TV that was broadcast on Saturday September 27th during the national 7.00 pm news bulletin and on the following day on Weekend Breakfast. The interview concerned the Company's efforts in bringing its drug candidate, Trilexium, into the clinic in Australia for the treatment of primary brain cancers such as glioblastoma multiforme. The...

2014-09-15 23:11:36

A collaborative study between researchers at the University of Colorado Cancer Center and the National Cancer Institute (NCI) published today in the journal Clinical Cancer Research takes an important step toward answering the question: which altered genes are most to blame for bladder cancer? AURORA, Colo. (PRWEB) September 15, 2014 The story of cancer care seems so simple: find the mutated gene that causes cancer and turn it off or fix it. But rarely does a single gene cause cancer....

2014-09-01 16:21:50

LONDON, Sept. 1, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Circulating Tumor Cell (CTC) Diagnostics: Technologies and Global Marketshttps://www.reportbuyer.com/product/2009162/Circulating-Tumor-Cell-CTC-Diagnostics-Technologies-and-Global-Markets.html STUDY GOALS AND OBJECTIVESThis report, PHM153A - Circulating Tumor Cell (CTC) Diagnostic: Technologies and Global Markets, gives market insight on monitoring tests used for cancer prognoses. The...

2014-08-25 08:28:14

WOONSOCKET, R.I., Aug. 25, 2014 /PRNewswire/ -- MultiCell Technologies, Inc. (OTC: MCET) has been issued U.S. patent 8,809,290 covering novel drug compositions and platform technologies which redirect the immune system response to protect against highly virulent virus infection and cancer. These novel drug compositions consisting of noncoding doubled stranded RNA (dsRNA) molecules and recombinant immunoglobulin-peptide (IgP) molecules demonstrate unique immune stimulating activity,...

2014-08-18 08:28:34

Proceedings of the National Academy of Sciences Study Shows Ability to Create Therapeutics Targeting Critical MYC Regulator for Potential Treatment of Cancer SAN DIEGO, Aug. 18, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), a late-stage clinical oncology company developing new treatments for cancer and its associated pain, today announced that data published in the Proceedings of the National Academy of Sciences (PNAS)(1) demonstrate the potential for the...

2014-08-14 08:29:14

-- Anti-EphA3 Agents Inhibit Tumor Growth by Disrupting or Destroying the Tumor Microenvironment: Malignant Stem Cells, Stromal Cells, and New Tumor Vasculature -- SOUTH SAN FRANCISCO, Calif., Aug. 14, 2014 /PRNewswire/ -- KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today announced the publication of preclinical findings describing EphA3 as a novel target expressed by a broad range of human tumors, and whose activation can lead to the selective disruption of the tumor microenvironment and...

2014-08-08 10:59:46

American Cancer Society Nearly one in ten cancer survivors reports smoking Nearly one in ten cancer survivors reports smoking many years after a diagnosis, according to a new study by American Cancer Society researchers. Further, among ten cancer sites included in the analysis, the highest rates of smoking were in bladder and lung cancers, two sites strongly associated with smoking. The study appears early online in Cancer Epidemiology, Biomarkers & Prevention. Cigarette smoking...

2014-08-04 09:40:28

University of California - San Diego Biomarker for head and neck cancers identified Although mutations in a gene dubbed "the guardian of the genome" are widely recognized as being associated with more aggressive forms of cancer, researchers at the University of California, San Diego School of Medicine have found evidence suggesting that the deleterious health effects of the mutated gene may in large part be due to other genetic abnormalities, at least in squamous cell head and neck...

2014-07-28 10:39:26

Baylor College of Medicine Cancer has long been thought to be primarily a genetic disease, but in recent decades scientists have come to believe that epigenetic changes – which don't change the DNA sequence but how it is 'read' – also play a role in cancer. In particular DNA methylation, the addition of a methyl group (or molecule), is an epigenetic switch that can stably turn off genes, suggesting the potential to cause cancer just as a genetic mutation can. Until now, however,...


Word of the Day
conjunto
  • A style of popular dance music originating along the border between Texas and Mexico, characterized by the use of accordion, drums, and 12-string bass guitar and traditionally based on polka, waltz, and bolero rhythms.
The word 'conjunto' comes through Spanish, from Latin coniūnctus, past participle of coniungere, to join together; see conjoin